Clinical Trial Update: Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study [NA]

View source ↗

Summary

Clinical trial on dual epicardial-endocardial ablation for persistent and longstanding persistent atrial fibrillation has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AtriCure, Inc. dual epicardial-endocardial ablation therapy

Snippet

Sponsor: AtriCure, Inc. | Conditions: Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2021-04-01